Private equity-backed Clario brings to Thermo Fisher Scientific software that collects, manages, and analyzes clinical trial endpoint data. Analysts see Clario’s offerings as highly complementary to PPD, the contract research organization that Thermo Fisher acquired in 2021.
The post Thermo Fisher Expands Biopharma Offerings With $9B Deal for Clinical Trial Software Firm Clario appeared first on MedCity News.
